As of 2025-07-09, the Intrinsic Value of Portage Biotech Inc (PRTG) is -317.00 USD. This PRTG valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.93 USD, the upside of Portage Biotech Inc is -5,445.76%.
Based on its market price of 5.93 USD and our intrinsic valuation, Portage Biotech Inc (PRTG) is overvalued by 5,445.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -317.00 - -317.00 | -317.00 | -5,445.76% |
| DDM - Stable | (532.66) - (1,930.58) | (1,231.62) | -20869.3% |
| DDM - Multi | (501.35) - (1,457.50) | (751.42) | -12771.5% |
| Market Cap (mil) | 6.65 |
| Beta | 2.26 |
| Outstanding shares (mil) | 1.12 |
| Enterprise Value (mil) | 3.35 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.64% |
| Cost of Debt | 5.00% |
| WACC | 9.60% |